2m 2m 2m 2m 2m 2m 2m
XILIO THERAP (XLO)
NASDAQ
$9.06-$0.18 (-1.95%)
Price as of Jul 14, 2026 10:12 AM EDT- $60.8MMarket Cap
- -10.76%1-Year Change
- BiotechnologyIndustry
XILIO THERAP (XLO)
$9.06-$0.18 (-1.95%)
XLO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.24 | ||
Change | +$0.14 (+1.54%) | ||
Open | $9.10 | ||
High | $9.32 | ||
Low | $8.98 | ||
Previous Close | $9.10 | ||
Volume | 71,451 | ||
30-Day Average Volume | 51,098 | ||
1-Week Change | -2.12% | ||
1-Month Change | 11.19% | ||
1-Year Change | -10.76% | ||
3-Year Change | -75.19% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 6.6M | ||
Total Assets | $163.5M | ||
Market Cap | $60.8M | ||
Enterprise Value | -$89.6M | ||
Period: QTR TTM FY | |||
Revenue | $12.6M | ||
Net Income | -$9.5M | ||
Free Cash Flow | -$22.9M | ||
EBIT | -$9.5M | ||
EBITDA | -$9.2M | ||
Net Working Capital | $111.2M | ||
EPS | -$0.58 | ||
Enterprise Value/EBITDA | 10 | ||
Enterprise Value/Revenue | -7 | ||
P/B | 1 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 14 | ||
Last Split Date | 03/16/2026 | ||
Earnings & Revenue